Finance Watch: Exo Raises $78m To Advance Exosite-Targeting Small Molecules
Platform Designed For More Precisely Targeted Drugs
Also, Atlas Venture and Advent France Biotechnology raise new venture capital funds, Corium secures $235m in debt to commercialize ADHD drug and CBMG leads recent VC financings with $120m series A round.
